Your browser doesn't support javascript.
loading
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
Aiello, Tommaso-Francesco; Puerta-Alcalde, Pedro; Chumbita, Mariana; Lopera, Carlos; Monzó, Patricia; Cortes, Albert; Fernández-Avilés, Francesc; Suárez-Lledó, María; Correa, Juan; Ortiz-Maldonado, Valentín; Cuesta, Genoveva; Martinez-Cibrian, Nuria; Esteve, Jordi; Marcos, Maria Ángeles; Mensa, Josep; Soriano, Alex; Garcia-Vidal, Carolina.
Afiliação
  • Aiello TF; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Puerta-Alcalde P; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Chumbita M; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Lopera C; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Monzó P; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Cortes A; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Fernández-Avilés F; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Suárez-Lledó M; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Correa J; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Ortiz-Maldonado V; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Cuesta G; Department of Microbiology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Martinez-Cibrian N; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Esteve J; Department of Haematology, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Marcos MÁ; Department of Microbiology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Mensa J; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Soriano A; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Garcia-Vidal C; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
J Antimicrob Chemother ; 78(6): 1454-1459, 2023 06 01.
Article em En | MEDLINE | ID: mdl-37051877
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Fármacos Dermatológicos / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Fármacos Dermatológicos / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha